Jubilant Pharmova Share Price | Jubilant Pharmova Stock Screener
JUBLPHARMA
Pharmaceuticals
Share Price NSE
₹991.75
▲
6.55 (0.66%)
Share Price BSE
₹991.25
▲
6.00 (0.61%)
As of May 27, 2026, the Jubilant Pharmova share price (NSE: JUBLPHARMA) is ₹991.75 on NSE and ₹991.25 on BSE, up 0.66% from the previous close, with shares trading between ₹977.45 and ₹993.95, and a 52-week range of ₹807.65–₹1,236.30.
Check Jubilant Pharmova 52-week for the annual price range and momentum.
Use the Jubilant Pharmova stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Jubilant Pharmova Market Cap
₹15,472.57 Cr.
JUBLPHARMA P/E Ratio (TTM)
40.31
Jubilant Pharmova P/B Ratio
2.43
EPS (TTM)
₹25.15
Dividend Yield
0.49%
Debt to Equity
0.55
JUBLPHARMA 52 Week High
₹1236.30
Jubilant Pharmova 52 Week Low
₹807.65
Operating Margin
14.00%
Profit Margin
5.18%
JUBLPHARMA Revenue (TTM)
₹2,296.00
EBITDA
₹332.00
Net Income
₹119.00
Total Assets
₹15,523.00
Total Equity
₹7,093.00
Jubilant Pharmova Share Price Chart
Screen Jubilant Pharmova share price with an interactive chart. Analyse JUBLPHARMA price trends and volatility across different timeframes.
Jubilant Pharmova Company Profile - Fundamental Screener
Screen Jubilant Pharmova company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for JUBLPHARMA shares.
Jubilant Pharmova Limited is an integrated global pharmaceutical and life sciences company. It operates in segments including Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing Organisation-Sterile Injectables, Generics, Contract Research, Development and Manufacturing Organisation, and Proprietary Novel Drugs. The company manufactures and supplies Active Pharmaceutical Ingredients, Solid Dosage Formulations, Radiopharmaceuticals, and...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Shyam S Bhartia
ISIN
INE700A01033
Website
https://www.jubl.com
Jubilant Pharmova Balance Sheet Screener
Screen JUBLPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 15,523 | 12,756 | 11,549 | 11,157 | 9,991 | 8,918 | 12,522 | 11,469 | 9,618 | 9,041 |
| Current Assets | 4,109 | 3,577 | 3,876 | 3,762 | 3,509 | 2,953 | 5,038 | 4,585 | 3,190 | 2,948 |
| Fixed Assets | 8,180 | 5,176 | 5,091 | 5,183 | 4,871 | 4,609 | 6,340 | 5,648 | 5,401 | 5,107 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 5,888 | 4,353 | 4,238 | 3,993 | 3,083 | 3,128 | 4,299 | 4,570 | 3,578 | 3,968 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 7,093 | 6,239 | 5,421 | 5,392 | 5,316 | 4,742 | 5,604 | 4,809 | 4,035 | 3,389 |
| Share Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves & Surplus | 7,077 | 6,239 | 5,418 | 5,383 | 5,303 | 4,726 | 5,588 | 4,793 | 4,071 | 3,421 |
Jubilant Pharmova Income Statement Screener - Profit & Revenue Analysis
Screen Jubilant Pharmova income statement and profit fundamentals.
Analyze JUBLPHARMA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Jubilant Pharmova share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,296 | 1,928 | 1,891 | 1,968 | 2,137 | 1,764 | 2,130 | 1,764 | 1,823 | 1,682 | 1,575 | 1,686 | 1,714 | 1,513 | 1,452 |
| Expenses | 1,964 | 1,587 | 1,611 | 1,631 | 1,873 | 1,656 | 1,480 | 1,477 | 1,554 | 1,459 | 1,419 | 1,439 | 1,459 | 1,280 | 1,259 |
| EBITDA | 332 | 341 | 280 | 337 | 264 | 108 | 650 | 287 | 269 | 223 | 156 | 247 | 255 | 233 | 192 |
| Operating Profit % | 14.00% | 17.00% | 14.00% | 17.00% | 12.00% | 5.00% | 14.00% | 15.00% | 14.00% | 12.00% | 9.00% | 14.00% | 12.00% | 15.00% | 13.00% |
| Depreciation | 117 | 95 | 98 | 105 | 121 | 101 | 91 | 91 | 91 | 271 | 90 | 97 | 95 | 101 | 95 |
| Interest | 57 | 53 | 49 | 50 | 56 | 73 | 71 | 61 | 56 | 56 | 62 | 66 | 71 | 40 | 40 |
| Profit Before Tax | 176 | 206 | 154 | 190 | 93 | -54 | 500 | 144 | 131 | -86 | 25 | 98 | 101 | 106 | 69 |
| Tax | 57 | 55 | 52 | 70 | 38 | 8 | 18 | 42 | 30 | 14 | 19 | 36 | 35 | 47 | 22 |
| Net Profit | 119 | 151 | 103 | 120 | 56 | -62 | 482 | 103 | 101 | -101 | 6 | 62 | 66 | 59 | 47 |
| EPS | 7.55 | 9.71 | 6.49 | 7.59 | 3.52 | -3.69 | 30.44 | 6.47 | 6.37 | -6.15 | 0.40 | 3.94 | 4.22 | 3.74 | 2.96 |
Jubilant Pharmova Cash Flow Screener - Liquidity Fundamentals
Screen JUBLPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1,072 | 971 | 661 | 838 | 1,784 | 1,543 | 1,122 | 1,303 | 1,269 | 1,099 |
| Investing Activities | 513 | -596 | -474 | -323 | -727 | -267 | -1,018 | -614 | -465 | -309 |
| Financing Activities | -1,453 | -433 | -157 | -33 | -1,709 | -1,050 | 657 | -901 | -686 | -843 |
| Net Cash Flow | 132 | -58 | 30 | 482 | -652 | 225 | 761 | -212 | 117 | -52 |
Jubilant Pharmova Shareholding Pattern Screener
See Jubilant Pharmova shareholding pattern with promoter, FII, and DII holdings.
Check Jubilant Pharmova promoter holding and ownership changes for JUBLPHARMA on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 47.68% | 50.68% | 47.68% | 47.68% | 47.68% | 50.68% | 50.68% | 50.68% |
| FII Holding | 15.90% | 17.22% | 17.40% | 16.57% | 15.96% | 19.06% | 19.49% | 17.94% |
| DII Holding | 11.62% | 7.05% | 9.53% | 10.52% | 11.22% | 3.78% | 4.07% | 5.66% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 17.57% | 17.75% | 17.97% | 18.02% | 17.85% | 18.71% | 17.79% | 18.09% |
| Other Holding | 7.23% | 7.31% | 7.42% | 7.22% | 7.29% | 7.77% | 7.97% | 7.63% |
| Shareholder Count | 86,347 | 96,526 | 99,673 | 93,336 | 90,133 | 92,264 | 81,992 | 89,456 |
Jubilant Pharmova Share Dividend Screener - Share Yield Analysis
Check Jubilant Pharmova dividend history with payout and yield data.
View Jubilant Pharmova dividend details including ex-dates and amounts for JUBLPHARMA stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹5.00 | 0.61% |
| 2024-March | ₹5.00 | 0.56% |
| 2023-March | ₹5.00 | 0.88% |
| 2022-March | ₹5.00 | 1.79% |
| 2021-March | ₹5.00 | 1.29% |
| 2020-March | ₹5.00 | 0.73% |
| 2019-March | ₹4.50 | 1.81% |
| 2018-March | ₹3.00 | 0.45% |
| 2017-March | ₹3.00 | 0.36% |
Jubilant Pharmova Stock Index Membership
See which indices include Jubilant Pharmova stock.
Check JUBLPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY 500
NIFTY MIDSML 400
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MOMENTUM 50
NIFTY500 MULTICAP
Jubilant Pharmova Market Events Screener - Corporate Actions
Get Jubilant Pharmova corporate actions including splits, bonuses, and buybacks.
Check Jubilant Pharmova stock events that may affect JUBLPHARMA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-22 | 2026-05-22 | Quarterly Result Announcement | NA | 6.97% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 2.93% |
| 2025-10-31 | 2025-10-31 | Quarterly Result Announcement | NA | 1.90% |
| 2025-08-29 | 2025-08-29 | Annual General Meeting | NA | -7.13% |
| 2025-07-29 | 2025-07-29 | Quarterly Result Announcement | NA | -2.98% |
| 2025-07-25 | 2025-07-25 | Dividend | ₹ 5.00 /share | 29.75% |
| 2025-05-16 | 2025-05-16 | Quarterly Result Announcement | NA | 1.03% |
| 2025-01-31 | 2025-01-31 | Quarterly Result Announcement | NA | 1.84% |
| 2024-10-25 | 2024-10-25 | Quarterly Result Announcement | NA | -9.79% |
| 2024-08-30 | 2024-08-30 | Annual General Meeting | NA | 8.43% |
| 2024-08-02 | 2024-08-02 | Dividend | ₹ 5.00 /share | 23.06% |
| 2023-08-10 | 2023-08-10 | Dividend | ₹ 5.00 /share | 11.53% |
| 2022-08-11 | 2022-08-12 | Dividend | ₹ 5.00 /share | -11.02% |
| 2021-08-05 | 2021-08-06 | Dividend | ₹ 5.00 /share | -22.02% |
| 2021-02-01 | 2021-02-01 | Change Of Name | NA | 0.00% |
Jubilant Pharmova Competitors Screener - Peer Comparison
Screen JUBLPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 442,749 | 40.42 | 58,220 | 6.38% | 11,565 | 54.75 |
| Divis Laboratories | 182,682 | 73.73 | 10,560 | 8.73% | 2,520 | 66.48 |
| Torrent Pharmaceuticals | 159,306 | 66.80 | 13,753 | 19.18% | 2,028 | 61.90 |
| Cipla | 113,081 | 29.26 | 27,712 | -2.46% | 3,783 | 61.92 |
| Dr Reddys Laboratories | 108,721 | 26.24 | 33,593 | -0.44% | 3,998 | 52.61 |
| Zydus Life Science | 105,665 | 20.40 | 26,720 | 13.65% | 5,242 | 69.40 |
| Lupin | 103,822 | 19.46 | 27,488 | 19.98% | 5,345 | 47.33 |
| Mankind Pharma | 102,190 | 52.84 | 14,278 | 12.03% | 1,750 | 62.34 |
| Aurobindo Pharma | 84,129 | 24.29 | 33,385 | 3.21% | 3,376 | 52.91 |
| Laurus Labs | 72,746 | 81.46 | 6,813 | 21.03% | 884 | 77.10 |
Jubilant Pharmova Company Announcements - News Screener
Screen JUBLPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-27 | Tax Demand Order Received By Companys Step Down Subsidiary | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-27 | Record Date | - |
| 2026-05-27 | Corporate Action-Board approves Dividend | - |
| 2026-05-27 | Audited Financial Results For The Quarter And Year Ended March 31. 2026 | - |
| 2026-05-27 | Board Meeting Outcome for Outcome Of Meeting Held On May 22 2026 | - |
| 2026-05-26 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-23 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-04-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-04-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-04-24 | Board Meeting Intimation for Meeting Held On May 22 2026 | - |
| 2026-04-01 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-31 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-03-30 | Submission Of Communication Sent To Shareholders | - |